A Bentley biotech company led by Graham Melrose is planning a $5 million initial public offering, after six years of research on the development of synthetic antibiotics.
EMBATTLED animal drug manufacturer Chemeq Ltd has been placed in administration and receivership after an appeal to overturn a court ruling ordering the company repay $60 million to its creditors fail
Martin Bruce Jones, Andrew John Saker and Darren Gordon Weaver of Ferrier Hodgson have been appointed as receivers and managers to Rockingham-based Chemeq Ltd, which went into administration on Wednesday.
Drug manufacturer Chemeq Ltd has been placed in administration after an appeal to overturn a court ruling ordering the company repay $60 million to its creditors failed.
Struggling animal pharmaceutical manufacturer Chemeq has been dealt another blow, with its entire production and maintenance staff walking out on the company following significant uncertainty about the group's financial future.
The Supreme Court will consider an application by Rockingham-based Chemeq Ltd to permit the implementation of a $75 million refinancing proposal from little-known International Finance Corporation of Australasia Pty Ltd tomorrow.
Beleagured Rockingham-based animal pharmaceutical products manufacturer Chemeq Ltd has announced a $75 million refinancing proposal from a little-known St Georges Terrace banker International Finance Corporation of Australasia Pty Ltd.
The vultures are circling, but Rockingham-based animal pharmaceutical products manufacturer Chemeq Ltd has life in it yet, as the Supreme Court yesterday restrained bondholders Stark Trading and Harmony Investment Fund from appointing a receiver.
CHEMEQ is appealing a court finding that it must repay $60 million to US bond trader Stark Trading and Harmony Capitol Partners after losing a previous appeal in the Supreme Court.
In what is seen as a last-ditch attempt to save the company, Rockingham-based animal pharmaceutical products manufacturer Chemeq Ltd will appeal a court finding that it must repay $60 million to its major financiers.
Rockingham-based animal pharmaceutical products manufacturer Chemeq Ltd has been ordered to repay $60 million to US bonds trader Stark Trading and Harmony Capital Partners after losing a Supreme Court appeal today.
Embattled animal pharmaceutical products manufacturer Chemeq Ltd has gone into a trading halt ahead of tomorrow's Supreme Court hearing into the company's application for an injunction against US bonds trader Stark Trading.
The dispute between embattled animal pharmaceutical products manufacturer Chemeq Ltd and US bonds trader Stark Trading will be adjourned to November 29 to permit a Supreme Court hearing.
Embattled Chemeq Ltd has announced that it will shortly be lodging an application with the Supreme Court of Western Australia for a declaration that it has met the revenue covenant set out in the Convertible Bond Deed Poll for the 2006 financial year.
Chemeq Ltd's share price has plummeted over 33 per cent after convertible bond holder Stark Trading and its associates issued the company with an early redemption notice, seeking repayment of bonds with a face value of $50 million.
Animal pharmaceutical products manufacturer Chemeq Ltd has signed a letter of intent with European chemicals manufacturer PCAS SA, which may lead to manufacturing and marketing partnerships.
